Market Research Logo

AnGes Inc (4563) - Financial and Strategic SWOT Analysis Review

AnGes Inc (4563) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two projects under development, namely, a hepatocyte growth factor (HGF) plasmid, a genetic medicine that regenerates blood vessels improving blood circulation and NF-KB decoy oligonuvleotide. It also develops therapeutic vaccine projects including, Allovectin, a cancer treatment drug; and DNA and CIN (cervical intraepithelial neoplasia) therapeutic vaccines. AnGes is headquartered in Osaka, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Section 1 - About the Company
AnGes Inc - Key Facts
AnGes Inc - Key Employees
AnGes Inc - Key Employee Biographies
AnGes Inc - Major Products and Services
AnGes Inc - History
AnGes Inc - Company Statement
AnGes Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AnGes Inc - Business Description
AnGes Inc - SWOT Analysis
SWOT Analysis - Overview
AnGes Inc - Strengths
AnGes Inc - Weaknesses
AnGes Inc - Opportunities
AnGes Inc - Threats
AnGes Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
AnGes Inc, Recent Deals Summary
Section 5 – Appendix
Ratio Definitions
About GlobalData
Contact Us
List of Tables
AnGes Inc, Key Facts
AnGes Inc, Key Employees
AnGes Inc, Key Employee Biographies
AnGes Inc, Major Products and Services
AnGes Inc, History
AnGes Inc, Other Locations
AnGes Inc, Subsidiaries
AnGes Inc, Key Competitors
AnGes Inc, Ratios based on current share price
AnGes Inc, Annual Ratios
AnGes Inc, Annual Ratios (Cont...1)
AnGes Inc, Interim Ratios
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
AnGes Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
AnGes Inc, Performance Chart (2013 - 2017)
AnGes Inc, Ratio Charts
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AnGes Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report